as on November 18, 2025 at 2:29 am IST
Day's Low
Day's High
0.33%
Downside
3.38%
Upside
52 Week's Low
52 Week's High
36.36%
Downside
45.70%
Upside
Check Mesoblast market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
-0.73
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-58.2M
Revenue (TTM)
17.2M
Profit Margin
0.00%
Return On Equity TTM
-18.95%
Compare market cap, revenue, PE, and other key metrics of Mesoblast with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.9B | -36.06% | NA | 0.00% | |
| BUY | $60.0B | 267.11% | 1448.9 | 1.36% | |
| NA | $43.9B | NA | 717.29 | 1.38% | |
| BUY | $110.9B | 100.61% | 30.76 | 31.35% | |
| BUY | $73.0B | 35.69% | 16.61 | 32.13% |
The Mesoblast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mesoblast investment value today
Current value as on today
₹1,47,142
Returns
₹47,142
(+47.14%)
Returns from Mesoblast Stock
₹42,051 (+42.05%)
Dollar Returns*
₹5,091 (+5.09%)
Based on 9 analysts
77.78%
Buy
22.22%
Hold
0.00%
Sell
Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Mesoblast. Average target price of $35
Get share price movements and forecasts by analysts on Mesoblast.
What analysts predicted
56.86%UPSIDE
Target Price
$35
Current Price
$15.1
Analyzed by
9 Analysts
Target
$35.00
Mesoblast target price $35, a slight upside of 56.86% compared to current price of $15.1. According to 9 analysts rating.
Search interest for Mesoblast Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 years, MESO stock has moved up by 144.2%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -27.70M → -23.96M (in $), with an average increase of 7.8% per quarter
Best in 3 Years
![]()
In the last 3 years, MESO has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 1.25M → 1.57M (in $), with an average increase of 10.2% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 100.7% return, outperforming this stock by 58.8%
| Organisation | Mesoblast |
| Headquarters | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
| Industry | Health Technology |
| CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Paul J. Simmons BSc, Ph.D. | Scientific Advisor to the Chief Executive Officer |
Mr. Justin Horst B.S. | Head of Manufacturing |
Mr. Marcelo Santoro | Chief Commercial Officer |
Ms. Niva Sivakumar B.Com., L.L.B. | Joint Company Secretary |
Mr. Peter T. Howard B.Sc., L.L.B. | General Counsel & Corporate Executive |
Dr. Eric A. Rose M.D. | Chief Medical Officer & Executive Director |
Mr. Andrew Chaponnel B.Com. | Interim Chief Finance Officer |
Ms. Geraldine Storton B.Sc., M.B.A., MMS | Head of Regulatory Affairs & Quality Management |
Dr. Fiona See Ph.D. | Senior VP & Head of Translational Research |
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) | Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director |
Mesoblast share price today is $15.1 as on at the close of the market. Mesoblast share today touched a day high of $15.61 and a low of $15.05.
Mesoblast share touched a 52 week high of $22 on and a 52 week low of $9.61 on . Mesoblast stock price today i.e. is closed at $15.1,which is 31.36% down from its 52 week high and 57.13% up from its 52 week low.
Mesoblast market capitalisation is $0.00T as on .
Indian investors can start investing in Mesoblast (MESO) shares with as little as ₹88.613 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.13 in Mesoblast stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mesoblast share’s latest price of $15.1 as on November 18, 2025 at 2:29 am IST, you will get 0.6623 shares of Mesoblast. Learn more about
fractional shares .
Mesoblast stock has given -36.06% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?